Inclusion and ethics statement The study presented here, has been approved and annually reviewed by the ethics board of the Ministry of Health of the Democratic Republic of the Congo (DRC) and the IRB board of the Oregon Health and Sciences University
Packaging of ZQ-II Anti-Aging GHK-Cu Serum (3ml x 3 vials)
In vivo studies in mice with acute and longterm hyperuricemia induced by potassium oxonate/hypoxanthine, the compounds exhibited significant hypouricemic potencies, which were slightly weaker and similar to febuxostat, at a dosage of 5 mg
Blend Composition PEPTIDE COMPONENTS BPC-157: 10mg (Body Protection Compound) GHK-Cu: 50mg (Copper Peptide) TB-500: 10mg (Thymosin Beta-4 Fragment) KPV: 10mg (Alpha-MSH C-Terminal Tripeptide) PHYSICAL PROPERTIES Total Weight: 80mg peptide blend Form: Lyophilized powder blend Color: White to off-white with blue tint (from GHK-Cu) Storage: Keep refrigerated 3646 F (28 C)
The evidence base here is thin and largely theoretical, but the concept aligns with established pharmacology of intranasal peptide delivery systems used for other compounds
These are rare but can include mild discomfort at the injection site